Newer Targeted Agents in NSCLC: ALK InhibitorsByAlice T. Shaw, MD, PhDJune 13th 2018Alice Shaw highlights the development and clinical considerations for use of first- and next-generation ALK inhibitors in NSCLC, plus ongoing research.